ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/12/11 | 3,875 | 3,875 | 3,780 | 3,782 | -95 | -2.5% | 245,200 |
| 2025/12/10 | 3,810 | 3,893 | 3,810 | 3,877 | +47 | +1.2% | 251,700 |
| 2025/12/09 | 3,796 | 3,830 | 3,761 | 3,830 | -1 | ±0% | 311,300 |
| 2025/12/08 | 3,862 | 3,863 | 3,810 | 3,831 | +9 | +0.2% | 186,700 |
| 2025/12/05 | 3,837 | 3,879 | 3,820 | 3,822 | -28 | -0.7% | 174,200 |
| 2025/12/04 | 3,755 | 3,866 | 3,755 | 3,850 | +46 | +1.2% | 299,500 |
| 2025/12/03 | 3,801 | 3,831 | 3,771 | 3,804 | -56 | -1.5% | 338,100 |
| 2025/12/02 | 3,811 | 3,864 | 3,810 | 3,860 | -1 | ±0% | 217,600 |
| 2025/12/01 | 3,903 | 3,908 | 3,847 | 3,861 | -48 | -1.2% | 247,600 |
| 2025/11/28 | 3,920 | 3,943 | 3,907 | 3,909 | -3 | -0.1% | 252,200 |
| 2025/11/27 | 3,880 | 3,915 | 3,863 | 3,912 | +15 | +0.4% | 232,400 |
| 2025/11/26 | 3,899 | 3,919 | 3,862 | 3,897 | +26 | +0.7% | 247,300 |
| 2025/11/25 | 3,852 | 3,881 | 3,830 | 3,871 | +19 | +0.5% | 251,700 |
| 2025/11/21 | 3,798 | 3,865 | 3,798 | 3,852 | +67 | +1.8% | 262,400 |
| 2025/11/20 | 3,768 | 3,825 | 3,763 | 3,785 | +30 | +0.8% | 294,200 |
| 2025/11/19 | 3,815 | 3,832 | 3,742 | 3,755 | -69 | -1.8% | 319,700 |
| 2025/11/18 | 3,825 | 3,866 | 3,815 | 3,824 | +9 | +0.2% | 354,000 |
| 2025/11/17 | 3,855 | 3,870 | 3,728 | 3,815 | -93 | -2.4% | 659,000 |
| 2025/11/14 | 3,919 | 3,950 | 3,896 | 3,908 | -8 | -0.2% | 295,600 |
| 2025/11/13 | 3,913 | 3,925 | 3,893 | 3,916 | +12 | +0.3% | 355,400 |
| 2025/11/12 | 3,964 | 3,974 | 3,853 | 3,904 | -39 | -1% | 663,800 |
| 2025/11/11 | 4,025 | 4,033 | 3,914 | 3,943 | -2 | -0.1% | 1,987,900 |
| 2025/11/10 | 3,613 | 3,965 | 3,556 | 3,945 | +396 | +11.2% | 2,257,000 |
| 2025/11/07 | 3,543 | 3,574 | 3,543 | 3,549 | +6 | +0.2% | 217,500 |
| 2025/11/06 | 3,553 | 3,573 | 3,542 | 3,543 | -10 | -0.3% | 180,800 |
| 2025/11/05 | 3,600 | 3,614 | 3,525 | 3,553 | -26 | -0.7% | 245,600 |
| 2025/11/04 | 3,567 | 3,614 | 3,558 | 3,579 | +4 | +0.1% | 299,200 |
| 2025/10/31 | 3,582 | 3,584 | 3,545 | 3,575 | +35 | +1% | 309,800 |
| 2025/10/30 | 3,520 | 3,542 | 3,509 | 3,540 | +40 | +1.1% | 324,900 |
| 2025/10/29 | 3,572 | 3,592 | 3,500 | 3,500 | -83 | -2.3% | 340,500 |
| 2025/10/28 | 3,655 | 3,661 | 3,583 | 3,583 | -92 | -2.5% | 396,000 |
| 2025/10/27 | 3,650 | 3,680 | 3,643 | 3,675 | +53 | +1.5% | 293,500 |
| 2025/10/24 | 3,648 | 3,663 | 3,617 | 3,622 | -26 | -0.7% | 261,300 |
| 2025/10/23 | 3,640 | 3,674 | 3,630 | 3,648 | +9 | +0.2% | 316,500 |
| 2025/10/22 | 3,634 | 3,666 | 3,632 | 3,639 | +5 | +0.1% | 453,400 |
| 2025/10/21 | 3,615 | 3,659 | 3,615 | 3,634 | +35 | +1% | 448,100 |
| 2025/10/20 | 3,586 | 3,616 | 3,566 | 3,599 | +60 | +1.7% | 418,200 |
| 2025/10/17 | 3,524 | 3,557 | 3,521 | 3,539 | -1 | ±0% | 224,200 |
| 2025/10/16 | 3,520 | 3,546 | 3,517 | 3,540 | +44 | +1.3% | 308,200 |
| 2025/10/15 | 3,493 | 3,519 | 3,488 | 3,496 | +29 | +0.8% | 296,900 |
| 2025/10/14 | 3,456 | 3,507 | 3,444 | 3,467 | -52 | -1.5% | 739,700 |
| 2025/10/10 | 3,557 | 3,574 | 3,519 | 3,519 | -72 | -2% | 385,500 |
| 2025/10/09 | 3,570 | 3,598 | 3,564 | 3,591 | -19 | -0.5% | 323,800 |
| 2025/10/08 | 3,594 | 3,635 | 3,587 | 3,610 | +13 | +0.4% | 371,900 |
| 2025/10/07 | 3,579 | 3,613 | 3,571 | 3,597 | +4 | +0.1% | 319,900 |
| 2025/10/06 | 3,583 | 3,595 | 3,562 | 3,593 | +42 | +1.2% | 443,100 |
| 2025/10/03 | 3,542 | 3,574 | 3,538 | 3,551 | +8 | +0.2% | 432,200 |
| 2025/10/02 | 3,578 | 3,581 | 3,503 | 3,543 | -1 | ±0% | 494,300 |
| 2025/10/01 | 3,623 | 3,625 | 3,544 | 3,544 | -77 | -2.1% | 444,700 |
| 2025/09/30 | 3,624 | 3,636 | 3,589 | 3,621 | -6 | -0.2% | 355,000 |
101～
150
件表示中 / 3942件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 377,800円 | +10.9% | -11.3% | 4.18% | 10.75倍 | 0.88倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ロート | 243,850円 | +7.5% | -3.9% | 2.05% | 15.97倍 | 1.83倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 日本新薬 | 423,700円 | +6.1% | -6.7% | 2.93% | 10.86倍 | 1.10倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 203,250円 | +7.1% | +526.4% | 2.71% | 16.77倍 | 1.33倍 |
|
後発医薬品大手で、幅広い取り扱い品目。２１年に沢井製薬が持株会社化。安定供給へ生産増強中 |
| キッセイ薬 | 430,500円 | -1.8% | - | 3.95% | 12.31倍 | 0.78倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
